tetrahydrocortisol has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the oral 11 beta-hydroxysteroid dehydrogenase-1 (11β-HSD1) inhibitor BI 187004 (NCT02150824), as monotherapy and in combination with metformin, versus placebo in patients with type 2 diabetes mellitus (T2DM) affected by overweight or obesity." | 5.69 | Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity. ( Bianzano, S; Heise, T; Nordaby, M; Peil, B; Plum-Mörschel, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianzano, S | 2 |
| Nordaby, M | 2 |
| Plum-Mörschel, L | 2 |
| Peil, B | 2 |
| Heise, T | 2 |
| Kobayashi, N | 1 |
| Masuzaki, H | 1 |
| Tanaka, T | 1 |
| Nakao, K | 1 |
1 review available for tetrahydrocortisol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
[The urinary index of intracellular glucocorticoid reactivation--a novel marker of metabolic syndrome and type 2 diabetes].
Topics: Biomarkers; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Tetrahydrocortisol; Tetrahydrocor | 2006 |
1 trial available for tetrahydrocortisol and Diabetes Mellitus, Adult-Onset